Rhumatologie

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL

A. Moltó1,C. López-Medina1,F. Van den Bosch1,A. Boonen1,C. Webers1,E. Dernis1F. A. Van Gaalen1,M. Soubrier1,P. Claudepierre1,A. Baillet1,M. Starmans-Kool1,D. Van der Heijde1,M. Dougados1


  1. TICOSPA Study Group, Paris, France

Abstract

Background: Current recommendations for axial spondyloarthritis (axSpA) management include tight control and treat-to-target (TC) strategies, but no study has evaluated its potential benefit

Objectives: To evaluate the benefit of TC strategies in comparison to usual care (UC) in patients with axSpA.

https://ard.bmj.com/content/79/Suppl_1/417.1

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of disease activity for patients with axial spondyloarthritis
Rhumatologie

Impact of disease activity for patients with axial spondyloarthritis

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis
Rhumatologie

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France